Solid Biosciences Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | — | $29.3M |
| Jun 2017 | — | — | $32.7M |
| Sep 2017 | — | — | $15.0M |
| Dec 2017 | — | $-59.3M | $52.1M |
| Mar 2018 | — | $179.0M | $164.8M |
| Jun 2018 | — | $162.3M | $145.8M |
| Sep 2018 | — | $145.1M | $129.1M |
| Dec 2018 | — | $125.2M | $86.4M |
| Mar 2019 | — | $99.1M | $54.0M |
| Jun 2019 | — | $76.5M | $51.8M |
| Sep 2019 | — | $108.5M | $94.7M |
| Dec 2019 | — | $80.0M | $76.0M |
| Mar 2020 | — | $56.5M | $53.2M |
| Jun 2020 | — | $40.7M | $40.4M |
| Sep 2020 | — | $22.2M | $24.8M |
| Dec 2020 | — | $132.1M | $154.7M |
| Mar 2021 | — | $253.0M | $268.5M |
| Jun 2021 | — | $237.9M | $200.6M |
| Sep 2021 | — | $223.4M | $109.7M |
| Dec 2021 | — | $208.2M | $119.1M |
| Mar 2022 | — | $185.5M | $129.7M |
| Jun 2022 | — | $162.2M | $54.3M |
| Sep 2022 | — | $143.3M | $48.8M |
| Dec 2022 | — | $211.7M | $155.4M |
| Mar 2023 | — | $183.8M | $164.6M |
| Jun 2023 | — | $163.7M | $91.6M |
| Sep 2023 | — | $144.4M | $49.0M |
| Dec 2023 | — | $126.5M | $74.0M |
| Mar 2024 | — | $210.7M | $117.6M |
| Jun 2024 | — | $193.2M | $95.9M |
| Sep 2024 | — | $167.0M | $64.4M |
| Dec 2024 | — | $137.2M | $80.2M |
| Mar 2025 | — | $294.5M | $210.6M |
| Jun 2025 | — | $258.3M | $138.9M |
| Sep 2025 | — | $217.9M | $61.4M |
| Dec 2025 | — | $180.0M | $59.9M |
| Mar 2026 | — | $374.1M | $297.1M |
| Jun 2026 | — | $374.1M | $159.4M |